课题基金 / 基金详情

Functional Tissue Replacement and Substitution: Platform Grant

Functional Tissue Replacement and Substitution: Platform Grant
功能组织替换和替代:平台资助
批准号:
EP/F043872/1
负责人:
John Fisher
金额:
$110.75万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

John Fisher的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our research in functional tissue replacement and substitution addresses both major societal needs and global economic opportunities. It impacts upon a spectrum of medical interventions from functional biomaterials and devices to tissue engineered constructs. It primarily focuses on degenerative deficiencies and ageing in the musculoskeletal and cardiovascular systems, by converging physical and biological sciences and technologies to address national and international opportunities. In particular it addresses the major societal needs of the functional ageing population, which has an increased retirement age, extended working life and increased longevity, by providing devices and therapeutic interventions to sustain mobility and relieve pain. Our research addresses increased patient expectation for earlier intervention, rapid rehabilitation, increased functional demand and personalized solutions.This will be delivered though research and development of devices and therapies that enable tissue preservation and regenerative capacity and more rapid restoration of natural biomechanical function. It will apply recent advances in biological sciences and nanoscale technologies, integrating this multidisciplinary science through a systems engineering approach to new technology discovery and product innovation.The program of research will build upon our previous research in wear of joint replacements in the hip and knee, in which we have researched and developed new materials and designs to provide longer lasting joints for young and active patients. It will address new approaches to partial joint replacement, cartilage substitution and tissue engineering, which have the potential to provide earlier intervention, tissue sparing and minimally invasive surgical therapies. It will also address functional tissue substitution in the spine, through bone preserving and augmentation therapies and new articulating implants and disc replacements. Particularly important in the spine is the development of functional simulation systems to replicate in the laboratory and in computer models the complex structure and function found in vivo. In the cardiovascular system novel biomimetic tissue scaffolds, which provide functional tissue regeneration solutions for blood vessels and heart valves, will be researched, through laboratory and clinical models.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1177/0954411913513251
发表时间: 2014-01
期刊: Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine
影响因子: --
作者: [Abdelgaied A, Brockett CL, Liu F, Jennings LM, Jin Z, Fisher J]
通讯作者: Fisher J
DOI: 10.1016/j.biomaterials.2013.01.023
发表时间: 2013-05-01
期刊: BIOMATERIALS
影响因子: 14
作者: [Behl, Bharat, Papageorgiou, Iraklis, Ingham, Eileen]
通讯作者: Ingham, Eileen
DOI: 10.1002/jbm.b.32904
发表时间: 2013-04
期刊: JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
影响因子: 3.4
作者: [Bladen, C. L., Teramura, S., Russell, S. L., Fujiwara, K., Fisher, J., Ingham, E., Tomita, N., Tipper, J. L.]
通讯作者: Tipper, J. L.
DOI: 10.1002/jbm.b.32824
发表时间: 2013-02
期刊: JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
影响因子: 3.4
作者: [Al-Hajjar, Mazen, Fisher, John, Williams, Sophie, Tipper, Joanne L., Jennings, Louise M.]
通讯作者: Jennings, Louise M.
6
    NSF/FDA SIR: 3D Human Stem Cell Cardiac Model for Cardiac Electrophysiology Medical Device Safety Assessment
    Collaborative Research: 4D Bioprinting of Near-infrared Light Responsive Smart Constructs for Pluripotent Stem Cell Derived Cardiomyocyte Engineering
    NSF/FDA Scholar In Residence: 3D Cell Adhesion Assay for Cellularized Scaffold Characterization and Enhancement
    Biohybrid Strategies for Decellularized Tissues
    海外基金